The European Parliament approved measures to address critical medicine shortages by enhancing EU manufacturing capacity, supporting local production, and promoting cross-border procurement. The focus is on antibiotics, insulin, vaccines, and medicines for chronic diseases. The goal is to reduce dependency on other countries, enhance competitiveness, and ensure public health protection. These initiatives aim to create strategic projects, prioritize EU production in procurement, and coordinate national stockpiles. The principle of "Buy European" in procurement is emphasized to ensure a secure supply of critical medicines. The Parliament is now moving towards negotiations with EU governments to finalize the legislation.